As in MF and SS, mutations affecting the JAK1-STAT3 signalling pathway are identified in primary cutaneous CD30-positive LPDs but only in a small minority of cases (5%) [47, 64]. The gene discussed is TNFRSF8; the disease is synovial sarcoma.